LLR Partners Makes Growth Investment in Genesee Scientific

Genesee Scientific Acquires Jade Scientific

September 15, 2025

Healthcare Services

Genesee Scientific, a portfolio company backed by LLR Partners, has acquired Jade Scientific, a Michigan-based distributor of chemicals and consumables for clinical reference, pharma/biotech, and environmental labs. The add-on expands Genesee’s lab essentials portfolio, broadening product offerings and strengthening service capabilities for customers nationwide.

Lakelet Capital Acquires GenTech Scientific

September 30, 2020

Industrial Services

Buffalo-based private equity firm Lakelet Capital has completed an investment to support the buyout of GenTech Scientific, a refurbisher, reseller, and servicer of analytical laboratory instrumentation based in Arcade, New York. The investment provides growth capital to enhance operations, extend geographic reach, and expand solution offerings; Lakelet also installed Michael Lippa as CEO and worked with GenTech founder Clair Bragg on the transition.

LLR Partners Makes Growth Investment in TruTechnologies

May 28, 2025

Healthcare Services

LLR Partners has made a strategic growth investment in TruTechnologies, a provider of real-time clinical trial oversight and sample-management software. The capital will support TruTechnologies' product and commercial expansion; BofA served as exclusive financial advisor to TruTechnologies while Wachtell, Lipton, Rosen & Katz and DLA Piper served as legal advisors to the respective parties.

LLR Partners Invests in Azalea Health

March 2, 2021

Healthcare Services

LLR Partners completed a growth investment in Azalea Health to provide capital for product innovation, organic expansion and potential acquisitions. The funding supports Azalea’s cloud-based EHR, telehealth and revenue cycle management SaaS platform for community and ambulatory healthcare providers.

Ampersand Capital Partners Invests in Genezen Laboratories

January 5, 2021

Biotechnology

Ampersand Capital Partners has made a majority growth-equity investment in Genezen Laboratories, a cell and gene therapy CDMO, to fund completion of a 25,000 sq. ft. cGMP lentiviral vector production facility and expand process development and analytical testing capabilities. The capital will support Genezen's capability expansion across upstream/downstream processing, analytical testing, and cGMP vector production to serve early‑phase and growth-stage cell and gene therapy developers.

L Squared Capital Partners / GSI Group Acquires Globe Scientific

April 28, 2022

Manufacturing

L Squared Capital Partners has acquired Globe Scientific and folded it into its GSI Group Holdings platform as the platform’s third add-on. Globe Scientific, a US-based maker and distributor of laboratory plasticware, glassware and benchtop equipment, will be integrated to expand GSI Group’s product portfolio, distribution footprint and reach into biopharma, diagnostics and academic research markets.